Fed. Circ. Won't Save Actelion's Suit Over Hypertension Drug
The Federal Circuit on Wednesday upheld a lower court's rejection of Actelion Pharmaceuticals' patent case against Viatris Inc. over its planned generic version of Actelion's hypertension drug, finding no issues with...To view the full article, register now.
Already a subscriber? Click here to view full article